These studies may denote a possible mechanism underlying AD-related neurodegeneration that involves impaired brain glucose uptake/metabolism due to decreased HIF-1, resulting in deficient expression of GLUT1 and GLUT3. This evidence concerns the gene SLC2A3 and Alzheimer disease.